🔎 Trials Near Me

Pradžia › Inksto nepakankamumas › Ilinoisas

Inksto nepakankamumas klinikiniai tyrimai Ilinoisas

7 tyrimai dėl Inksto nepakankamumas ieško dalyvių vietose Ilinoisas.

Miestai Ilinoisas

Oficialus tyrimo tekstas (anglų kalba)

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  • Research Site, Chicago
  • Research Site, Chicago
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 55 · Visoms lytims · Atnaujinta 2026-08-14 · NCT06749457

REgulatory T Cell Therapy to Achieve Immunosuppression REduction

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviai2 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-04-27 · NCT06552169

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  • Northwestern University, Chicago
Renkami dalyviai
Amžius nuo 18 iki 84 · Visoms lytims · Atnaujinta 2026-04-13 · NCT06190717

Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD

  • Northwestern Memorial Hospital, Chicago
Renkami dalyviai1/2 fazė
Amžius nuo 40 iki 70 · Visoms lytims · Atnaujinta 2026-03-27 · NCT06878560

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Northwestern University Feinberg School of Medicine, Chicago
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-24 · NCT06217302

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

  • Northwestern University, Chicago
Renkami dalyviaiStebimasis tyrimas
Amžius 21 ir vyresni · Visoms lytims · Atnaujinta 2026-03-18 · NCT07059962

Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors

  • Rush University Medical Center, Chicago
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-10 · NCT03803423

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.